Hepatocellular carcinoma after direct-acting antiviral therapy in kidney transplant recipients infected with hepatitis C virus
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
|---|---|
| Enthalten in: |
Nefrologia - 40(2020), 6 vom: 01. Nov., Seite 675-676 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Calça, Rita [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
49717AWG6K |
|---|
| Anmerkungen: |
Date Completed 01.10.2021 Date Revised 04.12.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.nefro.2019.11.005 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM305360345 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM305360345 | ||
| 003 | DE-627 | ||
| 005 | 20231225121016.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.nefro.2019.11.005 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1017.xml |
| 035 | |a (DE-627)NLM305360345 | ||
| 035 | |a (NLM)31937466 | ||
| 035 | |a (PII)S0211-6995(19)30212-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Calça, Rita |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hepatocellular carcinoma after direct-acting antiviral therapy in kidney transplant recipients infected with hepatitis C virus |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.10.2021 | ||
| 500 | |a Date Revised 04.12.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a Benzimidazoles |2 NLM | |
| 650 | 7 | |a Fluorenes |2 NLM | |
| 650 | 7 | |a alpha-Fetoproteins |2 NLM | |
| 650 | 7 | |a ledipasvir, sofosbuvir drug combination |2 NLM | |
| 650 | 7 | |a Ribavirin |2 NLM | |
| 650 | 7 | |a 49717AWG6K |2 NLM | |
| 650 | 7 | |a Sofosbuvir |2 NLM | |
| 650 | 7 | |a WJ6CA3ZU8B |2 NLM | |
| 700 | 1 | |a Jorge, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Lebre, Luís |e verfasserin |4 aut | |
| 700 | 1 | |a Cacheira, Eunice |e verfasserin |4 aut | |
| 700 | 1 | |a Querido, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Nascimento, Célia |e verfasserin |4 aut | |
| 700 | 1 | |a Adragão, Teresa |e verfasserin |4 aut | |
| 700 | 1 | |a Bruges, Margarida |e verfasserin |4 aut | |
| 700 | 1 | |a Weigert, André |e verfasserin |4 aut | |
| 700 | 1 | |a Machado, Domingos |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nefrologia |d 2018 |g 40(2020), 6 vom: 01. Nov., Seite 675-676 |w (DE-627)NLM270991409 |x 2013-2514 |7 nnns |
| 773 | 1 | 8 | |g volume:40 |g year:2020 |g number:6 |g day:01 |g month:11 |g pages:675-676 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.nefro.2019.11.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 40 |j 2020 |e 6 |b 01 |c 11 |h 675-676 | ||